For its May-ended first quarter, the drugstore chain expects net income between $35 million and $45 million with adjusted earnings of 4 cents a share. Analysts surveyed by Thomson Reuters forecast $76 million in net income and earnings of 8 cents a share.
For fiscal 2015 ending next February, Rite Aid lowered its EPS estimate to 30 cents to 40 cents, down from its previous range of 31 cents to 42 cents a share.
TheStreet Ratings team rates RITE AID CORP as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:
"We rate RITE AID CORP (RAD) a HOLD. The primary factors that have impacted our rating are mixed -- some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, poor profit margins and weak operating cash flow."